-
Je něco špatně v tomto záznamu ?
Genetically modified tumour vaccines: insertion of the IL-2 gene down regulates tumorigenicity more efficiently than insertion of the CD80 gene
P. Rossner, J. Bubenik, M. Indrova, V. Sobota, P. Vondrys, J. Zeuthen, T. Jandlova, M. Takac,
Jazyk angličtina Země Řecko
Typ dokumentu práce podpořená grantem
Grantová podpora
IZ3516
MZ0
CEP - Centrální evidence projektů
PubMed
21533347
DOI
10.3892/ijo.10.1.77
Knihovny.cz E-zdroje
- MeSH
- antigeny CD80 MeSH
- antitumorózní látky MeSH
- interleukin-2 MeSH
- myši MeSH
- protinádorové vakcíny MeSH
- sarkom genetika MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
Two genes, the gene coding for IL-2 and the gene encoding the CD80 molecule, were inserted into murine sarcoma MC12 cells. Tumorigenicity of a variety of cell clones with different expression of the inserted genes was assessed. Most of the genetically manipulated MC12 cell clones were less tumorigenic than the parental MC12 cell population. Tumorigenicity of the clones declined with increasing production of IL-2 as well as with the increasing expression of the CD80 molecule. When the tumorigenicity of the clones carrying an inserted IL-2 gene was compared with that of the clones carrying an inserted CD80 gene, it was found that the insertion of the IL-2 gene suppresses tumorigenicity more efficiently than insertion of the CD80 gene. Admixture of the IL-2-producing MC12 clones to the tumorigenic CD80(+) MC12 cell doses could completely inhibit the tumorigenicity of the CD80(+) cells. Insertion of the CD80 gene into sarcoma cells substantially enhanced the adhesive interaction between the MC12 sarcoma and syngeneic T lymphocytes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14046651
- 003
- CZ-PrNML
- 005
- 20140430124014.0
- 007
- ta
- 008
- 140219s1997 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3892/ijo.10.1.77 $2 doi
- 035 __
- $a (PubMed)21533347
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Rössner, Pavel, $d 1944- $7 jo2006324599 $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic
- 245 10
- $a Genetically modified tumour vaccines: insertion of the IL-2 gene down regulates tumorigenicity more efficiently than insertion of the CD80 gene / $c P. Rossner, J. Bubenik, M. Indrova, V. Sobota, P. Vondrys, J. Zeuthen, T. Jandlova, M. Takac,
- 520 9_
- $a Two genes, the gene coding for IL-2 and the gene encoding the CD80 molecule, were inserted into murine sarcoma MC12 cells. Tumorigenicity of a variety of cell clones with different expression of the inserted genes was assessed. Most of the genetically manipulated MC12 cell clones were less tumorigenic than the parental MC12 cell population. Tumorigenicity of the clones declined with increasing production of IL-2 as well as with the increasing expression of the CD80 molecule. When the tumorigenicity of the clones carrying an inserted IL-2 gene was compared with that of the clones carrying an inserted CD80 gene, it was found that the insertion of the IL-2 gene suppresses tumorigenicity more efficiently than insertion of the CD80 gene. Admixture of the IL-2-producing MC12 clones to the tumorigenic CD80(+) MC12 cell doses could completely inhibit the tumorigenicity of the CD80(+) cells. Insertion of the CD80 gene into sarcoma cells substantially enhanced the adhesive interaction between the MC12 sarcoma and syngeneic T lymphocytes.
- 650 _2
- $a antitumorózní látky $7 D000970
- 650 _2
- $a protinádorové vakcíny $7 D019496
- 650 _2
- $a interleukin-2 $7 D007376
- 650 _2
- $a antigeny CD80 $7 D018122
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a sarkom $x genetika $7 D012509
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bubeník, Jan, $d 1940- $7 jk01020086 $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic
- 700 1_
- $a Indrová, Marie $7 xx0069868 $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic
- 700 1_
- $a Sobota, Vesna $7 xx0183333 $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic
- 700 1_
- $a Vondrys, Pavel $7 xx0263755 $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic
- 700 1_
- $a Zeuthen, J
- 700 1_
- $a Jandlová, Táňa $7 xx0073341 $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic
- 700 1_
- $a Takac, Mirko $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic
- 773 0_
- $w MED00002350 $t International journal of oncology $x 1019-6439 $g Roč. 10, č. 1 (1997), s. 77-82
- 910 __
- $a ABA008 $b B 1837 $y 4 $z 0
- 990 __
- $a 20140219 $b ABA008
- 991 __
- $a 20140430124131 $b ABA008
- 999 __
- $a ok $b bmc $g 1013615 $s 845190
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 1997 $b 10 $c 1 $d 77-82 $i 1019-6439 $m International journal of oncology $n Int J Oncol $x MED00002350
- GRA __
- $a IZ3516 $p MZ0
- LZP __
- $a Pubmed-20140219